These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11363077)

  • 1. Lymphoma: MGBG new studies, compassionate use in earlier disease.
    Mascolini M
    AIDS Treat News; 1995 Dec; (no 237):4. PubMed ID: 11363077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma in AIDS.
    Majchrowicz M
    GMHC Treat Issues; 1995 Nov; 9(11):7-10. PubMed ID: 11362993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental cancer compound may be of benefit for AIDS-lymphoma.
    AIDS Patient Care STDS; 1996 Oct; 10(5):311. PubMed ID: 11361531
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma.
    Aboulafia DM
    Clin Infect Dis; 2002 Jun; 34(12):1660-2. PubMed ID: 12032910
    [No Abstract]   [Full Text] [Related]  

  • 5. Controversies in primary CNS lymphoma.
    Abrey LE
    Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system T-cell lymphoma in acquired immunodeficiency syndrome.
    Yotsumoto M; Funato K; Hashimoto Y; Fujimoto H; Fukutake K
    Br J Haematol; 2010 Mar; 148(5):807-8. PubMed ID: 19912221
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
    Siepmann K; Rohrbach JM; Duncker G; Zierhut M
    Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
    J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
    Schulz H; Pels H; Schmidt-Wolf I; Zeelen U; Germing U; Engert A
    Haematologica; 2004 Jun; 89(6):753-4. PubMed ID: 15194546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
    Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
    Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
    [No Abstract]   [Full Text] [Related]  

  • 12. MGBG: teaching an old drug new tricks.
    Von Hoff DD
    Ann Oncol; 1994 Jul; 5(6):487-93. PubMed ID: 7918120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary central nervous system lymphoma: risk factors and prophylaxis.
    Montoto S; Lister TA
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):751-63, viii. PubMed ID: 16083835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical and trial design considerations in central nervous system prophylaxis studies.
    Smith JA; Glantz M
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S69-76. PubMed ID: 19660685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma researchers in search of molecular targets.
    Friedrich MJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1000-1. PubMed ID: 20616351
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New combination for brain cancer.
    TreatmentUpdate; 1999 Aug; 11(6):4-6. PubMed ID: 11366935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary central nervous system lymphoma: a report of 28 patients].
    Hu Y; Feng FY; Shi YK; Zhou LQ; Gu DZ; Wang QL
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):375-8. PubMed ID: 15312352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab: new indication. In aggressive non Hodgkin lymphoma: benefits must be confirmed.
    Prescrire Int; 2003 Aug; 12(66):125-6. PubMed ID: 12906019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.